ASCEND BY NTHRYS
Research Abroad Products

Interactomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 49–60 of 200 project topics
Metastasis-Enabling Interaction Network Classifier
An AI-powered classification tool identifying metastasis-promoting protein interactions in primary tumors using patient tissue samples and clinical outcomes. Enables non-invasive early detection and prognosis prediction, creating high-margin diagnostic and monitoring revenue streams.
Interactomics Cancer Network Analytics Tools Click to view more details →
Multi-omics Cancer Interactome Integration Platform
An enterprise data integration platform unifying genomics, proteomics, phosphoproteomics, and imaging data to construct comprehensive cancer interactome models. Sells to biotech and pharma as a core discovery infrastructure, generating recurring SaaS revenue and accelerating time-to-IND filings.
Interactomics Cancer Network Analytics Tools Click to view more details →
AI-Powered Protein-Protein Interaction Prediction Platform
A SaaS platform leveraging machine learning to predict host-pathogen protein interactions and identify novel drug binding sites in real-time. Enables pharmaceutical companies to reduce drug discovery timelines by 40% and accelerate candidate validation workflows.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Interactome Mapping Software for Viral-Host Protein Networks
Enterprise software that constructs comprehensive 3D interactome maps from viral and human proteomes using high-throughput screening data integration. Generates actionable insights for biotech firms to develop multi-targeted antivirals with reduced off-target effects.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
High-Throughput Screening Data Integration and Analysis Tool
A cloud-based analytics platform that consolidates HTS, yeast two-hybrid, and co-immunoprecipitation datasets into unified interactome profiles. Monetizes through tiered SaaS subscriptions, enabling CROs and pharma to process 10x more screening data annually.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Bacterial Virulence Factor Target Discovery and Validation Service
A full-service platform combining computational screening with wet-lab validation to identify druggable bacterial virulence protein interactions. Delivers subscription-based recurring revenue through ongoing target validation and hit-to-lead optimization services.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Multi-Omic Pathogen-Host Interaction Database and Query Engine
A proprietary, regularly-updated database aggregating transcriptomics, proteomics, and structural data for 500+ human pathogens with interactive query tools. Generates B2B licensing revenue and premium tier access for pharmaceutical and academic research institutions.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Cryo-EM Structure-Based Drug Docking and Ranking Platform
An automated computational platform that leverages cryo-EM structural data of pathogen-host complexes to predict and rank drug candidates in seconds. Monetizes through per-project fees and exclusive partnerships with major pharmaceutical organizations.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Real-Time Pathogen Evolution Tracking and Interaction Prediction Engine
A continuous-update platform monitoring pathogen sequence variations and predicting how mutations alter host-pathogen protein interactions and drug efficacy. Supports pandemic response strategies and enables subscription-based early warning services for healthcare systems.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Synthetic Biology Assay Design for Host-Pathogen Interaction Screening
A design automation tool that generates optimized biosensor and reporter assay specifications for measuring specific host-pathogen interactions at scale. Creates value through licensing fees, assay kit sales, and integration with customer screening workflows.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Competitive Inhibitor Discovery Through Interactome Network Perturbation Analysis
A proprietary software suite that simulates interactome network perturbations to identify secondary and tertiary interaction targets for inhibitor design. Generates consulting revenue and technology licensing fees for precision antibiotic and antiviral development programs.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →
Integrated Biomarker and Target Validation Platform for Antimicrobial Resistance
An end-to-end platform combining host-pathogen interaction analysis with clinical biomarker discovery to de-risk antimicrobial resistance countermeasures. Delivers revenue through diagnostic co-development partnerships, assay licensing, and performance-based milestone agreements.
Host-Pathogen Interactomics Drug Target Platforms Click to view more details →